BLACK WEEKSBočice −15% · kompleti −10% · ostalo −5%s kodomBesplatna dostava u Njemačkoj od 200 €

Ova je stranica automatski prevedena i može sadržavati pogreške. Jeste li izvorni govornik? Rado ćemo primiti vaše povratne informacije i ispravke.Pošaljite povratne informacije

The Peptide Desk The Peptide Desk
P21, fotografija proizvoda
Cognition

P21

Cognition

  • Šalje se iz Njemačke

Narudžba

Jedinična cijena - Besplatna dostava u Njemačkoj iznad 200 € tijekom akcije Black Weeks
  • DHL s praćenjem
  • Diskretno pakiranje

4.6 od 5 na Trustpilotu73 recenzija

Na prvi pogled

P21 u brojkama

Ključni podaci iz našeg leksikona.

Cijeli članak u leksikonu
Class
CNTF mimetic / BDNF enhancer
Half-life
shorthence 2 doses per week
Use
Subcutaneous2x per week
Sizes
10 mg1 size in the shop

Znanje

Sve o P21

Detaljne informacije uskoro.

Doziranje

Učitavanje podataka o doziranju …

Više u leksikonu

Dobro je imati

Što vam uz to treba

Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.

Inzulinske štrcaljke

10 kom. · 5.50 €

Alkoholne maramice

50 kom. · 10 €

Koliko vode?

Jedinice na štrcaljki za veličinu vaše bočice.

Otvori kalkulator →

FAQ

Česta pitanja

Izvori za svaki odgovor: članak u leksikonu

Imate još pitanja?

Pišite nam, naš tim će vam pomoći.

Is P21 approved or studied in humans?

No. There is no approval and as of 26 October 2026 ClinicalTrials.gov lists no trial with P021. According to a conflict of interest statement from 2024 a company of the developer intends to develop P021 as a medicine. So far all data come from cells and animals.

What is P21 made of?

Of a tetrapeptide from the most active region of CNTF, plus a glycine with an adamantane group at the end. The formula is Ac-DGGL(A)G-NH2. The adamantane is meant to ease the way into the brain and slow breakdown by enzymes. The first paper from 2010 called the peptide P21, later ones P021.

What did the Alzheimer models show?

Mice with three Alzheimer genes received P021 for twelve months from an age of 9 to 10 months. Abnormal tau declined clearly, soluble amyloid fell, memory and the formation of new nerve cells improved. When dosing started at 3 months, tau and amyloid changes largely did not appear and fewer animals died. Even dosing only before and shortly after birth later reduced tau changes and amyloid plaques.

What did old rats show?

Rats aged 22 to 24 months lost less learning and memory performance with P021 and made more BDNF and more new nerve cells. A second paper showed that P021 reaches the brain and lowered the tau level in the cerebrospinal fluid to that of young rats, but not amyloid.

Are there findings outside Alzheimer's?

Yes, mixed ones. In a mouse model of Down syndrome dosing before and shortly after birth prevented developmental delay and later memory problems. In a model of CDKL5 disorder P021 helped in cell culture, but in mice BDNF did not rise and the benefit stayed small.

How was P021 given in the studies?

In the animal studies mostly with the food, so by mouth, often over many months. The lexicon entry instead describes dosing under the skin. There are no human data on that.

Which side effects are known?

There are no solid data because P021 has never been tested in humans. In old rats it caused no detectable immune reaction. That cannot be transferred to humans.

Povezano

Srodni proizvodi